CCDC191
geneOn this page
Summary
CCDC191 (coiled-coil domain containing 191, HGNC:29272) is a protein-coding gene on chromosome 3q13.31, encoding Coiled-coil domain-containing protein 191 (Q8NCU4).
At a glance
- Clinical variants (ClinVar): 149 total — 1 pathogenic
- MANE Select transcript:
NM_020817
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29272 |
| Approved symbol | CCDC191 |
| Name | coiled-coil domain containing 191 |
| Location | 3q13.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000163617 |
| Ensembl biotype | protein_coding |
| Entrez | 57577 |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 8 protein_coding, 2 nonsense_mediated_decay, 2 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000295878, ENST00000460813, ENST00000463695, ENST00000480588, ENST00000481358, ENST00000483766, ENST00000491000, ENST00000527855, ENST00000907458, ENST00000907459, ENST00000918262, ENST00000955809, ENST00000955810
RefSeq mRNA: 3 — MANE Select: NM_020817
NM_001353766, NM_001353767, NM_020817
CCDS: CCDS2977
Canonical transcript exons
ENST00000295878 — 17 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001241468 | 113978186 | 113978331 |
| ENSE00001241499 | 114004637 | 114004746 |
| ENSE00001241569 | 113964137 | 113965359 |
| ENSE00001241579 | 114056377 | 114056526 |
| ENSE00003486443 | 114053597 | 114053635 |
| ENSE00003488467 | 114002456 | 114002538 |
| ENSE00003500847 | 114034925 | 114035148 |
| ENSE00003517551 | 114018678 | 114018868 |
| ENSE00003525315 | 114046591 | 114046732 |
| ENSE00003543984 | 114031626 | 114031779 |
| ENSE00003554165 | 114036608 | 114036786 |
| ENSE00003557259 | 114010772 | 114011021 |
| ENSE00003561892 | 113980650 | 113980793 |
| ENSE00003568361 | 113978858 | 113979010 |
| ENSE00003578327 | 114042703 | 114042846 |
| ENSE00003664534 | 114001595 | 114001696 |
| ENSE00003785323 | 114005508 | 114005962 |
Expression profiles
Bgee: expression breadth ubiquitous, 195 present calls, max score 94.82.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.9145 / max 108.5483, expressed in 1362 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 43863 | 3.9145 | 1362 |
Top tissues by expression
249 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 94.82 | gold quality |
| bronchial epithelial cell | CL:0002328 | 92.30 | gold quality |
| bronchus | UBERON:0002185 | 90.86 | gold quality |
| sural nerve | UBERON:0015488 | 90.74 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 89.39 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 87.25 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.25 | gold quality |
| calcaneal tendon | UBERON:0003701 | 84.53 | gold quality |
| adenohypophysis | UBERON:0002196 | 84.06 | gold quality |
| kidney epithelium | UBERON:0004819 | 83.99 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 83.91 | gold quality |
| caput epididymis | UBERON:0004358 | 83.86 | gold quality |
| pituitary gland | UBERON:0000007 | 83.72 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 82.94 | gold quality |
| thyroid gland | UBERON:0002046 | 82.64 | gold quality |
| right testis | UBERON:0004534 | 82.03 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 81.98 | gold quality |
| metanephros cortex | UBERON:0010533 | 81.92 | gold quality |
| left testis | UBERON:0004533 | 81.88 | gold quality |
| testis | UBERON:0000473 | 81.17 | gold quality |
| ventricular zone | UBERON:0003053 | 81.02 | gold quality |
| tibial nerve | UBERON:0001323 | 79.94 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 79.62 | gold quality |
| nasopharynx | UBERON:0001728 | 79.61 | gold quality |
| body of pancreas | UBERON:0001150 | 79.44 | gold quality |
| fallopian tube | UBERON:0003889 | 78.89 | gold quality |
| left ovary | UBERON:0002119 | 78.62 | gold quality |
| body of uterus | UBERON:0009853 | 78.17 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 78.09 | gold quality |
| endocervix | UBERON:0000458 | 78.00 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-4 | yes | 55.64 |
| E-ANND-3 | yes | 9.43 |
| E-MTAB-6058 | no | 217.88 |
| E-MTAB-6379 | no | 174.24 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
59 targeting CCDC191, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-6748-5P | 100.00 | 65.81 | 1057 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-511-3P | 99.99 | 68.85 | 1467 |
| HSA-MIR-10401-5P | 99.99 | 65.79 | 948 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-374A-5P | 99.90 | 71.34 | 2923 |
| HSA-MIR-374B-5P | 99.90 | 69.98 | 2734 |
| HSA-MIR-548D-3P | 99.87 | 70.67 | 4362 |
| HSA-MIR-548BB-3P | 99.86 | 70.58 | 4354 |
| HSA-MIR-369-3P | 99.85 | 70.52 | 2264 |
| HSA-MIR-548AC | 99.84 | 70.77 | 4351 |
| HSA-MIR-548H-3P | 99.84 | 70.80 | 4349 |
| HSA-MIR-548Z | 99.84 | 70.80 | 4349 |
| HSA-MIR-4679 | 99.76 | 69.19 | 1229 |
| HSA-MIR-2681-5P | 99.75 | 67.64 | 1655 |
| HSA-MIR-6745 | 99.74 | 65.33 | 1321 |
| HSA-MIR-586 | 99.65 | 70.40 | 2051 |
| HSA-MIR-561-3P | 99.64 | 70.90 | 3647 |
| HSA-MIR-567 | 99.63 | 68.57 | 1219 |
| HSA-MIR-497-3P | 99.61 | 69.71 | 1990 |
| HSA-MIR-4452 | 99.50 | 68.45 | 1493 |
| HSA-MIR-5571-5P | 99.49 | 66.99 | 1764 |
| HSA-MIR-3123 | 99.47 | 67.15 | 2693 |
| HSA-MIR-363-5P | 99.46 | 64.51 | 1015 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ccdc191 | ENSDARG00000027851 |
| mus_musculus | Ccdc191 | ENSMUSG00000022701 |
| rattus_norvegicus | Ccdc191 | ENSRNOG00000057815 |
| drosophila_melanogaster | CG17258 | FBGN0031496 |
Paralogs (1): SFI1 (ENSG00000198089)
Protein
Protein identifiers
Coiled-coil domain-containing protein 191 — Q8NCU4 (reviewed: Q8NCU4)
All UniProt accessions (5): C9JA89, Q8NCU4, F8WCI8, F8WF68, H7C553
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8NCU4-1 | 1 | yes |
| Q8NCU4-2 | 2 |
RefSeq proteins (3): NP_001340695, NP_001340696, NP_065868* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR052270 | CACF_protein | Family |
UniProt features (15 total): coiled-coil region 4, region of interest 3, splice variant 3, sequence variant 2, compositionally biased region 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NCU4-F1 | 72.36 | 0.39 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 88 (showing top):
CAGCTG_AP4_Q5, AACWWCAANK_UNKNOWN, MYOD_01, MYCMAX_01, GRADE_COLON_AND_RECTAL_CANCER_UP, TGGAAA_NFAT_Q4_01, MYCMAX_03, MAX_01, AR_Q6, AP4_Q6_01, GKCGCNNNNNNNTGAYG_UNKNOWN, KIM_MYCN_AMPLIFICATION_TARGETS_DN, GSE14415_INDUCED_TREG_VS_TCONV_DN, BARX1_TARGET_GENES, CIITA_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
122 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CCDC191 | FAM9C | Q8IZT9 | 623 |
| CCDC191 | FBXW10B | O95170 | 564 |
| CCDC191 | BTBD16 | Q32M84 | 480 |
| CCDC191 | CIBAR2 | Q6ZTR7 | 473 |
| CCDC191 | FBXW10 | Q5XX13 | 448 |
| CCDC191 | LNX1 | Q8TBB1 | 405 |
| CCDC191 | CDK20 | Q8IZL9 | 401 |
| CCDC191 | RALGAPA1 | Q6GYQ0 | 391 |
| CCDC191 | STK24 | Q9Y6E0 | 389 |
| CCDC191 | CLCN4 | P51793 | 369 |
| CCDC191 | WBP2 | Q969T9 | 350 |
| CCDC191 | ZNF711 | Q9Y462 | 324 |
| CCDC191 | TENM4 | Q6N022 | 311 |
| CCDC191 | PSME4 | Q14997 | 295 |
| CCDC191 | ARHGEF28 | Q8N1W1 | 256 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CETN1 | SFI1 | psi-mi:“MI:0914”(association) | 0.640 |
| CALCOCO2 | TBKBP1 | psi-mi:“MI:0914”(association) | 0.640 |
| CCDC191 | RPN1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| CCDC191 | EEF1A1 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (10): KIAA1407 (Affinity Capture-MS), KIAA1407 (Proximity Label-MS), KIAA1407 (Proximity Label-MS), KIAA1407 (Affinity Capture-MS), KIAA1407 (Affinity Capture-MS), RRBP1 (Cross-Linking-MS (XL-MS)), KIAA1407 (Cross-Linking-MS (XL-MS)), KIAA1407 (Cross-Linking-MS (XL-MS)), THRAP3 (Cross-Linking-MS (XL-MS)), KIAA1407 (Affinity Capture-MS)
ESM2 similar proteins: A0AUP1, A0JMY4, A3KQH2, D6REC4, E1C760, F1QRC1, F1RKB1, F7AEX0, Q15051, Q17QH9, Q2IA00, Q32KY1, Q3USS3, Q3V079, Q3ZC62, Q45GW3, Q4R6T7, Q4R7Y8, Q4R8R3, Q4R8Y5, Q4V8E4, Q5PQQ6, Q5XI65, Q5XIR6, Q6P0R8, Q6P5U8, Q7T0Y4, Q7Z4T9, Q80VN0, Q8BP00, Q8BRC6, Q8C6E0, Q8C9J3, Q8CDK3, Q8CDV6, Q8HZY8, Q8NA47, Q8NA54, Q8NCU4, Q8ND07
Diamond homologs: Q8NCU4, Q95KD7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
149 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 114 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1077161 | GRCh37/hg19 3q13.31(chr3:113623035-114368128)x1 | Pathogenic |
SpliceAI
2869 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:113965360:C:CC | acceptor_gain | 1.0000 |
| 3:113965362:T:TC | acceptor_gain | 1.0000 |
| 3:113978328:CGTA:C | acceptor_gain | 1.0000 |
| 3:113978329:GTA:G | acceptor_gain | 1.0000 |
| 3:113978329:GTAC:G | acceptor_loss | 1.0000 |
| 3:113978332:C:A | acceptor_loss | 1.0000 |
| 3:113978332:C:CC | acceptor_gain | 1.0000 |
| 3:113978333:T:C | acceptor_loss | 1.0000 |
| 3:113978338:A:C | acceptor_gain | 1.0000 |
| 3:113978345:C:CT | acceptor_gain | 1.0000 |
| 3:113978346:A:T | acceptor_gain | 1.0000 |
| 3:113978852:CCTTA:C | donor_loss | 1.0000 |
| 3:113978853:CTTA:C | donor_loss | 1.0000 |
| 3:113978854:TTACC:T | donor_loss | 1.0000 |
| 3:113978855:TA:T | donor_loss | 1.0000 |
| 3:113978857:CCTG:C | donor_loss | 1.0000 |
| 3:113980644:GTGTA:G | donor_loss | 1.0000 |
| 3:113980645:TGTAC:T | donor_loss | 1.0000 |
| 3:113980646:GTACC:G | donor_loss | 1.0000 |
| 3:113980647:TACCT:T | donor_loss | 1.0000 |
| 3:113980648:A:T | donor_loss | 1.0000 |
| 3:113980790:CTTT:C | acceptor_gain | 1.0000 |
| 3:113980791:TTT:T | acceptor_gain | 1.0000 |
| 3:113980791:TTTC:T | acceptor_loss | 1.0000 |
| 3:113980792:TT:T | acceptor_gain | 1.0000 |
| 3:113980794:C:CC | acceptor_gain | 1.0000 |
| 3:113980794:CT:C | acceptor_loss | 1.0000 |
| 3:113980804:T:C | acceptor_gain | 1.0000 |
| 3:113980804:T:TC | acceptor_gain | 1.0000 |
| 3:114001592:AAC:A | donor_loss | 1.0000 |
AlphaMissense
6226 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:114018844:A:G | W333R | 0.986 |
| 3:114018844:A:T | W333R | 0.986 |
| 3:113980688:A:G | W757R | 0.984 |
| 3:113980688:A:T | W757R | 0.984 |
| 3:114036617:T:A | R195S | 0.980 |
| 3:114036617:T:G | R195S | 0.980 |
| 3:114018754:A:G | W363R | 0.978 |
| 3:114018754:A:T | W363R | 0.978 |
| 3:114036723:A:G | L160P | 0.969 |
| 3:114010960:A:G | W409R | 0.968 |
| 3:114010960:A:T | W409R | 0.968 |
| 3:114035135:C:G | R203P | 0.961 |
| 3:114018784:A:G | W353R | 0.960 |
| 3:114018784:A:T | W353R | 0.960 |
| 3:114036618:C:G | R195T | 0.956 |
| 3:114034973:C:G | R257P | 0.955 |
| 3:113965236:G:C | F910L | 0.952 |
| 3:113965236:G:T | F910L | 0.952 |
| 3:113965238:A:G | F910L | 0.952 |
| 3:114010958:C:A | W409C | 0.952 |
| 3:114010958:C:G | W409C | 0.952 |
| 3:114018752:C:A | W363C | 0.951 |
| 3:114018752:C:G | W363C | 0.951 |
| 3:114018842:C:A | W333C | 0.951 |
| 3:114018842:C:G | W333C | 0.951 |
| 3:114035126:C:G | R206P | 0.951 |
| 3:114042707:A:C | F137L | 0.951 |
| 3:114042707:A:T | F137L | 0.951 |
| 3:114042709:A:G | F137L | 0.951 |
| 3:114002525:T:A | R664S | 0.950 |
dbSNP variants (sampled 300 via entrez): RS1000031383 (3:113985480 A>G), RS1000040874 (3:113998902 G>A), RS1000134358 (3:113991582 G>C), RS1000162439 (3:114027804 C>T), RS1000171401 (3:114013047 T>G), RS1000234273 (3:114028326 C>T), RS1000254664 (3:113969931 C>T), RS1000374088 (3:113983680 C>T), RS1000413839 (3:113998558 G>A), RS1000450745 (3:114012668 T>C), RS1000466290 (3:114035382 A>C,G,T), RS1000467995 (3:113985991 G>C), RS1000471723 (3:113975954 C>G,T), RS1000602419 (3:114056069 A>G), RS1000631629 (3:113968622 T>TTTTG)
Disease associations
OMIM: gene `` | disease phenotypes: MIM:615433
GenCC curated gene-disease
Mondo (1): chromosome 3q13.31 deletion syndrome (MONDO:0014185)
Orphanet (1): 3q13 microdeletion syndrome (Orphanet:1621)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C536808 | Chromosome 3, monosomy 3q13 (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
14 total (human), top 14 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression | 2 |
| Acetaminophen | decreases expression, increases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| jinfukang | increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Benzo(a)pyrene | decreases expression | 1 |
| Estradiol | affects expression | 1 |
| Nickel | decreases expression | 1 |
| Plant Extracts | increases expression, affects cotreatment | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): chromosome 3q13.31 deletion syndrome